RGC
#1546
Regencell Bioscience Holdings Limited - Ordinary Shares
7.1 9 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.84%
Variación mensual
+27.71%
Variación en los últimos 6 meses
-78.26%
Cambio anual
-57.71%
Cierres anteriores
7.1 3
Open
7.1 6
Mínimo
7.0 9
Máximo
7.2 3
Financials
- Market Capitalization 3.57 B
- Employee 10
- Founded 2014
- CEO N/A
- Website www.regencellbioscience.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Fabricantes de medicamentos — especializados y genéricos
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.57
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1132 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 19.78 USD | -1.25% | -3.13% | +15.60% | +87.49% | 6.32 B USD | ||
| 1415 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 35.86 USD | -0.55% | 0.00% | +3.22% | +6.73% | 4.23 B USD | ||
| 1802 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 42.67 USD | -0.33% | +0.12% | +1.21% | -20.98% | 2.48 B USD | ||
| 1826 |  HCM HUTCHMED (China) Limited - American Depositary Shares | 13.55 USD | -0.95% | -7.19% | +1.50% | -9.61% | 2.36 B USD |